The 2025 Cell Research Symposia Cancer Biology was jointly hosted by Hainan Medical University, Center for Excellence in Molecular Cell Science CAS and Cell Research in Haikou from March 26 to 28. The conference attracted over 70 leading scientists, clinical doctors, and industry representatives from multiple countries worldwide, who engaged in in-depth discussions focusing on fundamental research in cancer biology, translational medicine, and clinical treatment strategies.
The conference, themed "Cancer Biology", covered cutting-edge topics such as the regulation of tumor microenvironment, metabolic reprogramming, gene editing, and immunotherapy. The opening ceremony was held by Gao Daming professor from Center for Excellence in Molecular Cell Science CAS.
In his opening address, president Chen Guoqiangextended a warm welcome to all the guests. He highlighted HNMU's significant developments with the supports from various sectors over the past year, as well as the critical mission in advancing the Hainan Free Trade Port, and expressed eagerness for talented individuals to join the university in contributing to the Free Trade Port's development.
In his speech, Professor Li Dangsheng introduced the original intent behind hosting this conference, the development history and editorial mission of Cell Research, and expressed hope that participating experts would actively exchange ideas to strengthen the integration of basic research and clinical translation, thereby advancing progress in precision cancer therapy.
Wang Xiaofan Academician
Li Mengfeng Professor
Xu Chenqi Professor
Liu Mingyao Professor
Scott W. Lowe Professor
Toshiro Sato Professor
The forum featured an intensive agenda packed with over 30 specialized sessions on cancer biology. This conference not only provided a high-caliber global platform for scientific exchange but also showcased China's innovative dynamism in cancer research. Participating experts unanimously called for strengthened international collaboration to accelerate the translation of fundamental discoveries into clinical applications, jointly addressing cancer as a critical challenge to global health.
